Associate Director, Sub-Regional Marketing Business Partner - France

France

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Genomic TechnologyIndustries

Requirements

Candidates should possess a strong understanding of healthcare, commercial, and research customer types, along with expertise in branding, content creation and deployment, and digital marketing. A solid grasp of the unique needs of marketing in France is essential. The ideal candidate will combine creativity and analytics to drive impactful local marketing campaigns, demonstrating subject matter expertise, market awareness, business acumen, and leadership skills. Cross-functional collaboration in a matrixed organization is critical for success.

Responsibilities

The Associate Director will develop, manage, and implement strategic marketing plans aligned with sub-regional business plans for Illumina's product portfolio and new product introductions in France. They will create go-to-market strategies and execute them with clear milestones, ensuring relevance to the French market and customers while aligning with Illumina's strategies and branding. This role involves developing a marketing tactics flight plan using shared resources, coordinating activities, and ensuring alignment of strategies and clear metrics for effectiveness. Additionally, the position requires balancing operational expenses with revenue commitments and assessing marketing key performance indicators for the customer pipeline.

Skills

Marketing Strategy

Go-to-Market Tactics

Branding

Content Creation

Digital Marketing

Market Insights

Product Portfolio Management

Competitive Intelligence

Demand Generation

Pipeline Management

Healthcare Marketing

Commercial Marketing

Research Marketing

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free